ATE53024T1 - Biologisch aktive substanz, girolline genannt, extrahiert aus dem schwamm pseudaxinyssa cantharella, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. - Google Patents

Biologisch aktive substanz, girolline genannt, extrahiert aus dem schwamm pseudaxinyssa cantharella, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE53024T1
ATE53024T1 AT86401600T AT86401600T ATE53024T1 AT E53024 T1 ATE53024 T1 AT E53024T1 AT 86401600 T AT86401600 T AT 86401600T AT 86401600 T AT86401600 T AT 86401600T AT E53024 T1 ATE53024 T1 AT E53024T1
Authority
AT
Austria
Prior art keywords
pseudaxinyssa
cantharella
girolline
sponge
extracted
Prior art date
Application number
AT86401600T
Other languages
English (en)
Inventor
Alain Ahond
Pierre Laboute
Dominique Laurent
Pierre Potier
Christiane Poupat
Jacques Pusset
Nee Thillou Michele Pusset
Odile Thoison
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Application granted granted Critical
Publication of ATE53024T1 publication Critical patent/ATE53024T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88Nitrogen atoms, e.g. allantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/655Aquatic animals other than those covered by groups A61K35/57 - A61K35/65
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Oceanography (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT86401600T 1985-07-18 1986-07-17 Biologisch aktive substanz, girolline genannt, extrahiert aus dem schwamm pseudaxinyssa cantharella, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. ATE53024T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8510997A FR2585020B1 (fr) 1985-07-18 1985-07-18 Nouvelle substance biologiquement active, appelee girolline, extraite de l'eponge pseudaxinyssa cantharella, son procede de preparation et les compositions pharmaceutiques qui la contiennent
EP86401600A EP0215687B1 (de) 1985-07-18 1986-07-17 Biologisch aktive Substanz, Girolline genannt, extrahiert aus dem Schwamm Pseudaxinyssa cantharella, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE53024T1 true ATE53024T1 (de) 1990-06-15

Family

ID=9321411

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86401600T ATE53024T1 (de) 1985-07-18 1986-07-17 Biologisch aktive substanz, girolline genannt, extrahiert aus dem schwamm pseudaxinyssa cantharella, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Country Status (7)

Country Link
US (1) US4801602A (de)
EP (1) EP0215687B1 (de)
JP (1) JPS6277372A (de)
AT (1) ATE53024T1 (de)
CA (1) CA1248116A (de)
DE (1) DE3671444D1 (de)
FR (1) FR2585020B1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646848A1 (fr) * 1989-05-12 1990-11-16 Rhone Poulenc Sante Nouvelle substance antitumorale, un procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2646849A1 (fr) * 1989-05-12 1990-11-16 Rhone Poulenc Sante Procede de preparation d'une nouvelle substance antitumorale, l'amino-3 (amino-2 1h-imidazolyl-4)-1 chloro-2 propanol-1 et de ses sels sous forme racemique threo, utilisable comme medicament
FR2652351A1 (fr) * 1989-09-26 1991-03-29 Rhone Poulenc Sante Nouveau derive de l'imidazolepropanamide, sa preparation et son emploi.
EP0656210A1 (de) * 1993-11-19 1995-06-07 Takeda Chemical Industries, Ltd. Imidazolderivate als Hemmer der Glutaminase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3804850A (en) * 1972-10-25 1974-04-16 Dow Chemical Co Method of preparing 1,5-disubstituted-2-haloimidazoles
AU529815B2 (en) * 1981-05-15 1983-06-23 Fisons Plc Optically active imidazole derivatives

Also Published As

Publication number Publication date
EP0215687A1 (de) 1987-03-25
JPS6277372A (ja) 1987-04-09
US4801602A (en) 1989-01-31
DE3671444D1 (de) 1990-06-28
CA1248116A (fr) 1989-01-03
FR2585020B1 (fr) 1987-10-02
FR2585020A1 (fr) 1987-01-23
EP0215687B1 (de) 1990-05-23

Similar Documents

Publication Publication Date Title
IL76457A (en) Tetralin derivatives,their preparation and pharmaceutical compositions containing them
ATE26705T1 (de) 1-carboxyalkanoylindolin-2-carbonsaeuren und deren derivate, verfahren zu ihrer herstellung, und pharmazeutische praeparate, die diese verbindungen enthalten.
PT79735A (de) 11beta-aryl-estradiene deren herstellung und diese enthaltende pharmazeutische praeparate
EP0221041A3 (de) Benzimidazolderivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
FR2680507B1 (fr) Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE22077T1 (de) 1-phenylisochinolinderivate und verfahren zu ihrer herstellung, diese verbindung enthaltende pharmazeutische praeparate und deren anwendung.
DE3380958D1 (de) Beta-carboline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
GR3022632T3 (en) Isoquinolin-5yl-sulphonamides, process for their preparation and pharmaceutical compositions containing them
EP0173664A3 (de) Biologisch aktive Benzimidazolderivate und Verfahren zu ihrer Herstellung
PT82512A (fr) Procede de preparation de derives de quinolylglycinamides ayant activite psychotrope et de compositions pharmaceutiques les contenant
ATE48137T1 (de) Neue benzodipyrrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ES8602725A1 (es) Procedimiento de preparacion de bencensulfonamidas y similares.
YU242789A (en) New compound, 4-fluoro-2-//(4-metoxy-2-pyridin-yl)methylsulphinyl/-1h-benzimidazole and process for obtaining
HUT51221A (en) Process for producing pharmaceutical compositions comprising 3-demethyl-4-fluoromevalonic acid derivatives and the active ingredients
ATE66230T1 (de) Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE18050T1 (de) Triazolochinazoline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DE69201368D1 (de) 1-(Alkoxybenzyl)piperazineamide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
ATE107298T1 (de) 3-aminochroman-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE53024T1 (de) Biologisch aktive substanz, girolline genannt, extrahiert aus dem schwamm pseudaxinyssa cantharella, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3575139D1 (de) Phenylnaphthyridine, verfahren zu deren herstellung, diese enthaltende arzneimittel, insbesondere antigeschwuer.
HU900753D0 (en) Process for preparation of phenylhydrazones and for pharmaceutical compositions containing them
ATE27157T1 (de) Cycloalkylderivate von benzisoselenazolonen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
IL89335A (en) 6-oxo-pyridazine derivatives, a process for their preparation and pharmaceutical compositions containing these compounds
ATE40349T1 (de) Difluorcyclopropanderivate, verfahren zu ihrer herstellung sowie schaedlingsbekaempfungsmittel enthaltend diese verbindungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee